In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: PennyMac appears undervalued with a 16.1% implied upside and a high-confidence fair value near $8.14 versus the $7.01 price. Weak financial health scores and high valuation volatility (99.05% coefficient of variation) indicate elevated investment risk despite positive median Monte Carlo outcomes. Divergent valuation methods and negative DCF midpoint highlight fundamental uncertainty.